Trial Profile
Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety, and Tolerability of Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects With Chronic Lower Back Pain Requiring Opioid Analgesia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Mar 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors BioDelivery Sciences International; Endo Pharmaceuticals
- 26 Oct 2015 Results presented in Endo Pharmaceuticals media release.
- 26 Oct 2015 According to Endo Pharmaceuticals media release, the US FDA has approved BELBUCATM (buprenorphine) buccal film for use in patients with chronic pain
- 14 May 2015 Results published in an Endo Pharmaceuticals media release.